Trial · NCT02755298
Chronic Clinical Effect of Acetazolamide
NCT02755298, Phase 2, Phase 3, Completed, University of Zurich
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Chronic Clinical Effect of Acetazolamide. Trials, record NCT02755298. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02755298
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Chronic Clinical Effect of Acetazolamide
- NCT number
- NCT02755298
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 24 participants, estimated
- Lead sponsor
- University of Zurich
- Conditions
- Hypertension, Pulmonary
- Interventions
- Acetazolamide, Placebo
- First posted
- 2016-04-28
- Last updated
- 2020-12-19
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference in 6 min walk distance | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Difference of Quality of Life (QoL) assessed by the physical subscale of the living with pulmonary hypertension questionnaire (MLHF) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Progressive maximal ramp cardiopulmonary exercise testing | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | cerebral and muscle tissue oxygenation | 5 weeks | At the end of both periods (AZA and Placebo) at rest and exercise |
| Secondary | daily activity | 5 weeks | actigraphy |
| Secondary | morphological and functional parameters of the heart | 5 weeks | measured by echocardiography |
| Secondary | New York Heart Association functional class | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Short-form medical outcome questionnaire (SF-36) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) | 5 weeks | At the end of both periods (AZA and Placebo) |
| Secondary | N-terminal pro-brain natriuretic Peptide (NT-proBNP) | 5 weeks | At the end of both periods (AZA and Placebo) |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 36639329 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02755298
GET https://conductscience.org/api/trials/v1/NCT02755298/registered